Paul F. McKenzie
2017
In 2017, Paul F. McKenzie earned a total compensation of $5M as Executive Vice President, Pharmaceutical Operations & Technology at Biogen.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $2,471 |
|---|---|
| Non-Equity Incentive Plan | $796,648 |
| Salary | $600,433 |
| Stock Awards | $3,514,451 |
| Other | $101,254 |
| Total | $5,015,257 |
McKenzie received $3.5M in stock awards, accounting for 70% of the total pay in 2017.
McKenzie also received $2.5K of change in pension value and nonqualified deferred compensation earnings, $796.6K in non-equity incentive plan, $600.4K in salary and $101.3K in other compensation.
Rankings
In 2017, Paul F. McKenzie's compensation ranked 1,887th out of 14,666 executives tracked by ExecPay. In other words, McKenzie earned more than 87.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,887 out of 14,666 | 87th |
Division Manufacturing | 634 out of 5,772 | 89th |
Major group Chemicals And Allied Products | 168 out of 2,075 | 92nd |
Industry group Drugs | 123 out of 1,731 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 27 out of 313 | 91st |
Source: SEC filing on April 27, 2018.
McKenzie's colleagues
We found eight more compensation records of executives who worked with Paul F. McKenzie at Biogen in 2017.
2017
Michel Vounatsos
Biogen
Chief Executive Officer
2017
George Scangos
Biogen
Chief Executive Officer
2017
Kenneth DiPietro
Biogen
Former Executive Vice President, Human Resources
2017
Michael Ehlers
Biogen
Executive Vice President, Research & Development
2017
Susan Alexander
Biogen
Chief Legal Officer
2017
Paul Clancy
Biogen
Chief Financial Officer
2017
Gregory Covino
Biogen
Chief Accounting Officer
2017
Jeffrey Capello
Biogen